Kalaris Therapeutics Inc
KLRS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12 | -$11 | -$10 | – |
| Dep. & Amort. | $0 | $0 | $0 | – |
| Deferred Tax | $0 | $0 | $0 | – |
| Stock-Based Comp. | $0 | $0 | $0 | – |
| Change in WC | -$0 | -$2 | $2 | – |
| Other Non-Cash | $1 | -$2 | $0 | – |
| Operating Cash Flow | -$11 | -$15 | -$7 | – |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | $0 | – |
| Net Acquisitions | $0 | $0 | $0 | – |
| Inv. Purchases | -$35 | $0 | $0 | – |
| Inv. Sales/Matur. | $0 | $0 | $0 | – |
| Other Inv. Act. | $0 | $0 | $0 | – |
| Investing Cash Flow | -$35 | $0 | $0 | – |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $8 | $8 | – |
| Stock Issued | $0 | $0 | $0 | – |
| Stock Repurch. | $0 | $0 | $0 | – |
| Dividends Paid | $0 | $0 | $0 | – |
| Other Fin. Act. | $0 | -$5 | $100 | – |
| Financing Cash Flow | $0 | $2 | $107 | – |
| Forex Effect | $0 | $0 | $0 | – |
| Net Chg. in Cash | -$46 | -$13 | $100 | – |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88 | $101 | $2 | – |
| End Cash | $42 | $88 | $101 | – |
| Free Cash Flow | -$12 | -$15 | -$7 | – |